Progyny (NASDAQ:PGNY) and Alignment Healthcare (NASDAQ:ALHC) Head-To-Head Survey

Progyny (NASDAQ:PGNY) and Alignment Healthcare (NASDAQ:ALHC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends and profitability.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Progyny and Alignment Healthcare, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Progyny	0	3	9	1	2.85
Alignment Healthcare	0	3	6	2	2.91

Progyny presently has a consensus target price of $28.55, indicating a potential upside of 22.78%. Alignment Healthcare has a consensus target price of $24.60, indicating a potential upside of 56.39%. Given Alignment Healthcare’s stronger consensus rating and higher probable upside, analysts plainly believe Alignment Healthcare is more favorable than Progyny.

Valuation & Earnings

This table compares Progyny and Alignment Healthcare”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Progyny	$1.29 billion	1.41	$58.52 million	$0.77	30.19
Alignment Healthcare	$3.95 billion	0.82	-$720,000.00	$0.09	174.78

Progyny has higher earnings, but lower revenue than Alignment Healthcare. Progyny is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Progyny has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500.

Insider and Institutional Ownership

94.9% of Progyny shares are held by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are held by institutional investors. 9.9% of Progyny shares are held by company insiders. Comparatively, 5.2% of Alignment Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Progyny and Alignment Healthcare’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Progyny	5.23%	13.34%	9.03%
Alignment Healthcare	0.47%	11.50%	1.79%

Summary

Progyny beats Alignment Healthcare on 9 of the 15 factors compared between the two stocks.

About Progyny

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

About Alignment Healthcare

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.